AMGEN NEUPOGEN INFECTIOUS DISEASE USES IN DEVELOPMENT: RESULTS FROM PNEUMONIA TRIALS ARE LIKELY AT MID-MAY THORACIC SOCIETY; SEPSIS, LIVER TRANSPLANTS ALSO
Executive Summary
Amgen will report results from a Phase III study with Neupogen (filgrastim) in community-acquired pneumonia at the upcoming May 10-15 meeting of the American Lung Association and American Thoracic Society in New Orleans.